Drug Shortage Report for ATROPINE SULFATE INJECTION USP
| Report ID | 43076 |
| Drug Identification Number | 00328154 |
| Brand name | ATROPINE SULFATE INJECTION USP |
| Common or Proper name | ATROPINE SULFATE LIFESHIELD |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ATROPINE SULFATE |
| Strength(s) | 0.1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
| Packaging size | 10 x 10mL |
| ATC code | A03BA |
| ATC description | BELLADONNAAND DERIVATIVES, PLAIN |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2018-05-25 |
| Estimated end date | |
| Actual end date | 2018-07-13 |
| Shortage status | Resolved |
| Updated date | 2018-07-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.